One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
A Half-Century of Progress in Health: The National Academy of Medicine at 50: Women’s Health — Traversing Medicine and Public Policy
Cynthia A. Stuenkel, M.D., and JoAnn E. Manson, M.D., Dr.P.H.
doi : 10.1056/NEJMp2105292
N Engl J Med 2021; 384:2073-2076
Institutional Problems, Individual Solutions — The Burden on Black Physicians
Alyssa M. Newman, Ph.D.
doi : 10.1056/NEJMp2103063
N Engl J Med 2021; 384:2076-2078
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
Richard P. Whitlock, M.D., Ph.D., Emilie P. Belley-Cote, M.D., Ph.D., Domenico Paparella, M.D., Jeff S. Healey, M.D., et al., for the LAAOS III Investigators*
doi : 10.1056/NEJMoa2101897
N Engl J Med 2021; 384:2081-2091
Surgical occlusion of the left atrial appendage has been hypothesized to prevent ischemic stroke in patients with atrial fibrillation, but this has not been proved. The procedure can be performed during cardiac surgery undertaken for other reasons.
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Andreas Greinacher, M.D., Thomas Thiele, M.D., Theodore E. Warkentin, M.D., Karin Weisser, Ph.D., et al.
doi : 10.1056/NEJMoa2104840
N Engl J Med 2021; 384:2092-2101
Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChAdOx1 nCov-19, AstraZeneca). More data were needed on the pathogenesis of this unusual clotting disorder.
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
Dean F. Bajorin, M.D., J. Alfred Witjes, M.D., Jürgen E. Gschwend, M.D., Michael Schenker, M.D., et al.
doi : 10.1056/NEJMoa2034442
N Engl J Med 2021; 384:2102-2114
The role of adjuvant treatment in high-risk muscle-invasive urothelial carcinoma after radical surgery is not clear.
Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers
Milagritos D. Tapia, M.D., Samba O. Sow, M.D., Abdi Naficy, M.D., Fatoumata Diallo, M.D., et al.
doi : 10.1056/NEJMoa2013615
N Engl J Med 2021; 384:2115-2123
Neisseria meningitidis serogroups A, B, C, W, X, and Y cause outbreaks of meningococcal disease. Quadrivalent conjugate vaccines targeting the A, C, W, and Y serogroups are available. A pentavalent vaccine that also includes serogroup X (NmCV-5) is under development.
Brief Report: Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Nina H. Schultz, M.D., Ph.D., Ingvild H. S?rvoll, M.D., Annika E. Michelsen, Ph.D., Ludvig A. Munthe, M.D., Ph.D., et al.
doi : 10.1056/NEJMoa2104882
N Engl J Med 2021; 384:2124-2130
HIV Infection — Screening, Diagnosis, and Treatment
Michael S. Saag, M.D.
doi : 10.1056/NEJMcp1915826
N Engl J Med 2021; 384:2131-2143
Gastrointestinal Amyloidosis
Shinji Izuka, M.D., and Hiroyuki Yamashita, M.D., Ph.D.
doi : 10.1056/NEJMicm2034179
N Engl J Med 2021; 384:2144
Speech-Induced Atrial Tachycardia
André Zimerman, M.D., and Andre d’Avila, M.D., Ph.D.
doi : 10.1056/NEJMicm2030596
N Engl J Med 2021; 384:e83
Hypertensive Heartbreak
Emily S. Lau, M.D., Benjamin Scirica, M.D., M.P.H., Inga-Marie Schaefer, M.D., Amy L. Miller, M.D., Ph.D., et al.
doi : 10.1056/NEJMcps2018493
N Engl J Med 2021; 384:2145-2152
The Closing Argument for Surgical Left Atrial Appendage Occlusion
Richard L. Page, M.D.
doi : 10.1056/NEJMe2106069
N Engl J Med 2021; 384:2154-2155
Audio Interview: Vaccinating Children
Eric J. Rubin, M.D., Ph.D., Lindsey R. Baden, M.D., and Stephen Morrissey, Ph.D.
doi : 10.1056/NEJMe2109334
N Engl J Med 2021; 384:e103
An Allergic Basis for Abdominal Pain
Marc E. Rothenberg, M.D., Ph.D.
doi : 10.1056/NEJMcibr2104146
N Engl J Med 2021; 384:2156-2158
Rapid Sequencing-Based Diagnosis of Thiamine Metabolism Dysfunction Syndrome
doi : 10.1056/NEJMc2100365
N Engl J Med 2021; 384:2159-2161
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)
doi : 10.1056/NEJMc2104192
N Engl J Med 2021; 384:2161-2163
Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease
doi : 10.1056/NEJMc2102124
N Engl J Med 2021; 384:2163-2165
